Becton Dickinson (BDX) Non-Current Debt (2009 - 2026)
Becton Dickinson's (BDX) quarterly Non-Current Debt came in at $14.7 billion in Q1 2026, down 16.76% year-on-year from $17.7 billion in Q1 2025, and down 13.06% on a QoQ basis from $16.9 billion in Q4 2025.
Becton Dickinson (BDX) Non-Current Debt (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Non-Current Debt data on file, last reported at $14.7 billion in Q1 2026.
- On a quarterly basis, Non-Current Debt fell 16.76% year-over-year to $14.7 billion in Q1 2026; TTM through Mar 2026 was $14.7 billion, a 16.76% decrease from a year earlier, with the FY2025 full-year figure at $17.6 billion, down 1.78% from the prior year.
- Non-Current Debt for Q1 2026 stood at $14.7 billion, down from $16.9 billion in the prior quarter.
- Over the last five years, Non-Current Debt for BDX reached as high as $18.1 billion in Q2 2024 and fell as low as $13.9 billion in Q3 2022.
- Historically, Non-Current Debt has averaged $16.1 billion across 5 years, with a median of $16.0 billion in 2023.
- On a YoY basis, Non-Current Debt climbed as much as 2315.38% in 2022 and fell as far as 18.84% in 2022.
- Year by year, Non-Current Debt stood at $14.3 billion in 2022, then dropped by 1.22% to $14.1 billion in 2023, then advanced by 23.74% to $17.4 billion in 2024, then fell by 3.0% to $16.9 billion in 2025, then declined by 13.06% to $14.7 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $14.7 billion in Q1 2026, $16.9 billion in Q4 2025, and $17.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 4.16 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 14.71 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 12.50 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 404.17 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.86 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.58 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 8.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.71 Bn |
| Dec 31, 2025 | 16.92 Bn |
| Sep 30, 2025 | 17.62 Bn |
| Jun 30, 2025 | 17.53 Bn |
| Mar 31, 2025 | 17.67 Bn |
| Dec 31, 2024 | 17.44 Bn |
| Sep 30, 2024 | 17.94 Bn |
| Jun 30, 2024 | 18.13 Bn |
| Mar 31, 2024 | 16.00 Bn |
| Dec 31, 2023 | 14.09 Bn |
| Sep 30, 2023 | 14.74 Bn |
| Jun 30, 2023 | 14.93 Bn |
| Mar 31, 2023 | 16.01 Bn |
| Dec 31, 2022 | 14.27 Bn |
| Sep 30, 2022 | 13.89 Bn |
| Jun 30, 2022 | 14.68 Bn |
| Mar 31, 2022 | 17.58 Bn |
| Dec 31, 2021 | 16.36 Bn |
| Sep 30, 2021 | 17.11 Bn |
| Jun 30, 2021 | 15.70 Bn |